Serum growth arrest-specific protein 6 levels are elevated in adult-onset Still's disease

Clin Rheumatol. 2014 Jun;33(6):865-8. doi: 10.1007/s10067-014-2629-8. Epub 2014 Apr 27.

Abstract

We investigated the growth arrest-specific protein 6 in adult-onset Still's disease. Serums were collected from 52 adult-onset Still's disease patients with follow-up samples of 21 patients. The growth arrest-specific protein 6 levels in adult-onset Still's disease were higher compared to those in the normal controls (25.37±7.71 vs. 19.86±5.01 ng/mL, p<0.001). However, growth arrest-specific protein 6 did not correlate with disease activity. Also, growth arrest-specific protein 6 was not decreased after activity was resolved in the follow-up. The growth arrest-specific protein 6 in adult-onset Still's disease patients were higher than the normal controls. However, growth arrest-specific protein 6 was not correlated with disease activity.

MeSH terms

  • Adult
  • Biomarkers / blood
  • Case-Control Studies
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Gene Expression Regulation*
  • Humans
  • Intercellular Signaling Peptides and Proteins / blood*
  • Male
  • Middle Aged
  • Reproducibility of Results
  • Republic of Korea
  • Still's Disease, Adult-Onset / blood*

Substances

  • Biomarkers
  • Intercellular Signaling Peptides and Proteins
  • growth arrest-specific protein 6